Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
National
Rachel Flynn

Cancer patients to receive ‘life-changing’ AstraZeneca drug through NHS

PA Media

Olaparib, manufactured by pharmaceutical company AstraZeneca, could benefit hundreds who suffer from breast cancer and prostate cancer.

Men with advanced prostate cancer and women with a form of early breast cancer called HER2-negative will be able to access olaparib through NHS England if they are at high risk of the disease returning.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.